Pharmaceutical

Gilead and Genesis partner to create novel therapies using AI

Gilead Sciences has partnered with Genesis Therapeutics to discover and develop new small molecule therapies using AI.

Sep 12, 2024 - 04:00
Gilead and Genesis partner to create novel therapies using AI
Gilead Sciences has partnered with Genesis Therapeutics to discover and develop new small molecule therapies using AI.
Read the original article

Tags:

Previous Article

Sanofi inaugurates vaccine plant in Neuville-sur-Saône, France

Next Article

Prodrugs and patents: Enhancing therapy adherence and reducing side effects 

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

UCB to divest China neurology and allergy business for $680m

UCB to divest China neurology and allergy business for ...

Aug 27, 2024

Invivyd receives FDA IND clearance for VYD222 to prevent Covid-19

Invivyd receives FDA IND clearance for VYD222 to preven...

Apr 26, 2023

Revenue growth for 13 of top 20 biopharmas with obesity drug successes in 2023

Revenue growth for 13 of top 20 biopharmas with obesity...

Aug 1, 2024